TruthArchive.ai - Related Video Feed

The speaker asks if the Pfizer COVID vaccine was tested for its ability to stop virus transmission before being released. They request a clear yes or no answer and the data to be shared with the committee. The response states that they did not have prior knowledge of stopping transmission before the vaccine entered the market and had to rely on scientific research. Another speaker expresses outrage, claiming that people were pressured to get vaccinated based on the false belief that it would protect others.

I think we all know how important the COVID vaccine was. It was scientifically, critically studied to prevent severe disease. I think where people started to get confused is when we started to make potential claims that the vaccine did more than what it was studied to actually show. And remember all of those original studies, we didn't test patients unless they had symptoms. We only looked for disease, and so we don't know how many people were asymptomatic. We don't know about protection against infection. What we did know about is protection against severe disease. And clearly, if you look at the mortality in individuals 75 before vaccination and after vaccination, there was a dramatic difference even through, Amicrom and Delta. So, yes, the vaccine was highly effective for what it was intended to do, was prevent Shouldn't the health secretary know that? You know, I'm not sure that there's so much confusion about the COVID vaccine, what it was studied to do. I just want to make it very clear. It was studied to prevent severe disease, and that's what it does. And then I think the question is, well, who's who's susceptible to severe disease and who should continue to get the COVID shots? I think that's what needs to be clearly laid out to the American people.

Speaker 0 asked for the impossible: to develop a vaccine in 8 months instead of 10 years without cutting corners. They emphasized safety. Speaker 1 questioned Pfizer's transparency in mutating COVID viruses. Speaker 0 stressed the importance of vaccination for public health. Pfizer's CEO discussed vaccine production and effectiveness. They thanked the US government for support. The CEO highlighted the vaccine's 95.6% efficacy. The conversation ended with a call for public vaccination.

According to our data from the CDC today, vaccinated people do not carry the virus and do not get sick. This finding is not limited to clinical trials; it is also supported by real-world data.

The speaker asked if the Pfizer COVID vaccine was tested for stopping virus transmission before it was released. They wanted a clear yes or no answer and requested the data to be shared with the committee. In response, it was stated that no, they did not have knowledge about stopping transmission before the vaccine entered the market. They had to act quickly.

The speaker acknowledges that the vaccine did not completely stop the spread or infection, but clarifies that initially it did for the Wuhan strain and the alpha strain. Early data and literature published in the New England Journal showed that those who were vaccinated and didn't get infected were not transmitting the virus to others. The vaccine had a high efficacy of up to 96% early on and this efficacy did not change over time.

The White House blames a few bad actors for spreading online misinformation that is causing harm. It is important to get vaccinated not only for personal protection but also to safeguard society. A member of the European Parliament from the Netherlands recently had a viral exchange with a Pfizer executive regarding whether the vaccine was tested for stopping virus transmission before being released. The executive clarified that the vaccines were extensively tested in clinical trials, but their specific effectiveness in stopping transmission was not known prior to market entry.

Speaker 0 questions understanding of vaccine causing myocarditis, mentioning Pfizer's awareness. Speaker 1 doubts if vaccine was tested for stopping transmission before market release. Speaker 0 believes vaccination was optional, not forced.

A year ago, the speaker requested data from Emma, including all clinical trials done by medical companies before they requested marketing authorization for the green certificate. Regarding Pfizer, the speaker notes the company submitted a clinical trial that started on January 14, 2020. The speaker questioned a Pfizer representative about how tests for the vaccine began so soon after the December 2019 emergence of COVID-19, but the representative declined to answer. The speaker also asked the CEO of Moderna how they submitted trials since 2017, years before the virus was discovered in the winter of 2019. The speaker states that the CEO of Moderna did not answer how this was possible. The speaker says these are legitimate questions that people are asking, but unfortunately, the companies are declining to answer.

I spoke with Pfizer's CEO, Albert Bourla, about the approval process. We discussed vaccine safety and serious side effects. Many companies and institutions are embracing the COVID vaccine due to its effectiveness. Logistics are crucial in this process. Translation (if needed): I talked to Pfizer's CEO, Albert Bourla, about the approval process. We talked about vaccine safety and serious side effects. Many companies and institutions are adopting the COVID vaccine because it works well. Logistics are important in this situation.

Pfizer was asked if they tested whether their COVID-19 vaccine could reduce or stop the transmission of the virus before its approval. The Pfizer representative stated that the primary purpose of the vaccine was to protect the person who received it and prevent illness, severe disease, and hospitalizations. The senator then referred to a statement made by Pfizer's CEO on December 3, 2020, where he mentioned uncertainty about the vaccine's ability to reduce transmission. The Pfizer representative reiterated that their clinical programs were designed to demonstrate the vaccine's safety and effectiveness in preventing infections. Due to time constraints, the senator moved on without a definitive answer.

The speakers discuss the importance of vaccination in reducing transmission and returning to normalcy. They express confidence in the vaccines' ability to prevent illness and transmission. They emphasize the need for people to get vaccinated for their own protection and to break the chain of transmission. Vaccinated individuals are seen as dead ends for the virus, preventing further spread. However, it is mentioned that initial data on vaccine effectiveness against transmission was limited at the time of emergency use authorization. A question is raised about whether the Pfizer vaccine was tested for transmission prevention before its release, to which the response is that they had to move quickly based on scientific progress.

Speaker 0 acknowledges reports of myocarditis and pericarditis associated with the Pfizer vaccine but seems unsure about the mechanism behind it. Speaker 1 asks if the vaccine was tested for its ability to stop virus transmission before being released. Speaker 2 questions if people were forced to get vaccinated to keep their jobs and asks Speaker 0 to retract their statement. Speaker 0 clarifies that everyone had the choice to get vaccinated or not, and they don't believe anyone was forced.

The Pfizer COVID vaccine was not tested for its ability to stop the transmission of the virus before it entered the market. The speaker acknowledges that they had to work quickly to understand the situation and move at the speed of science.

The speaker acknowledges that the vaccine did not completely stop the spread or infection, but clarifies that initially it did for the Wuhan strain and the alpha strain. Early data and literature published in the New England Journal showed that those who were vaccinated and didn't get infected were not transmitting the virus to others. The vaccine had a high efficacy of up to 96% early on and this efficacy did not change over time.

The speaker acknowledges that the vaccine did not completely stop the spread or infection, but clarifies that initially it did for the Wuhan strain and the alpha strain. Early data and literature published in the New England Journal showed that those who were vaccinated and didn't get infected were not transmitting the virus to others. The vaccine had a high efficacy of up to 96% early on and this efficacy did not change over time.

The speaker asked if the Pfizer COVID vaccine was tested for stopping virus transmission before it was released. They requested a clear yes or no answer and asked for the data to be shared with the committee. The speaker then stated that they did not have knowledge about stopping immunization before the vaccine entered the market.

Pfizer's claim of 96% efficacy for their vaccine was questioned. The study and data were not independently verified, and Pfizer wanted to keep the data hidden for 75 years. The true effectiveness of the vaccine, based on absolute risk reduction, is less than 1%. More people died and were harmed in their trials compared to the placebo group. The vaccine's safety was questionable from the start, and it is not effective. Additionally, appropriate studies were not conducted for new variants.

A year ago, the speaker requested data from Emma, including clinical trials from medical companies before they sought marketing authorization for their products. Regarding Pfizer, the speaker notes that the company submitted a clinical trial that started on January 14, 2020. The speaker questioned a Pfizer representative about how Pfizer started testing a vaccine in January 2020, just days after the Chinese government released DNA data about the virus in December 2019, but the representative declined to answer. The speaker also mentions that Moderna submitted trials dating back to 2017. The speaker asked the CEO of Moderna how it was possible to submit vaccine tests years before the virus was discovered in December 2019. The speaker states that these are legitimate questions that people are asking, but unfortunately, the companies are declining to answer.

Pfizer knew a month into the rollout, November 2020, that this vaccine did not work to stop COVID. Everything that followed—the mandates, the lost jobs, the closures, children not allowed back to school if they didn’t take the shot, the armed forces compelled to take it, pilots compelled—was built on a lie of vaccine efficacy. The most common side effect of getting vaccinated is COVID, and Pfizer understood that the vaccine’s efficacy and vaccine failure showed it did not stop COVID. They also knew the injection did not stay in the deltoid. Europeans through the EMA and public health entities described side effects as chills, fever, fatigue, needing to lie down, but Pfizer knew that was a lie. In Pfizer documents, charts show that the materials—the spike protein, the mRNA, the lipid nanoparticles, and polyethylene glycol—biodistribute within forty-eight hours and leave the injection site to biodistribute to major organs throughout the body, crossing the blood-brain barrier. This may have contributed to personality changes in some loved ones who took the injection. They also accumulate in the liver, the adrenals, the spleen, the lymphatic system, and in women, the ovaries. The first injection accumulates in ovaries; the second injection more so. Experts could not find any mechanism whereby this material left the body in either gender. By the first booster, surgeries on vaccinated women reported fully blocked ovaries, among other damage. Pfizer knew that. They also hired 2,400 full-time staff to process reports of serious adverse events, starting to receive them during the 2020-2021 period. In Pfizer documents, over forty-two thousand serious adverse events were tallied from November 2020 to February 2021, with many individuals experiencing multiple events. The top documented side effects included myalgia (muscle pain), followed by joint pain, then COVID itself, and then a catastrophic tally of serious side effects including heart damage (myocarditis, pericarditis), problems with the aorta, thrombotic events (blood clots in various locations), neurological events (tremors, Guillain-Barré, dementia, epilepsy-like seizures), autoimmune disorders, and eye damage including blindness. Reproductive damage was noted: miscarriages and other issues. Twelve hundred deaths in three months were recorded as not statistically random; they were old with prior conditions, yet doctors noted causality concerns and recorded them. Pfizer knew by April 2021 that minors were injured by the vaccine, specifically myocarditis and pericarditis. Minors sustained heart damage, with thirty-five minors affected. The Israeli Ministry of Health warned the CDC and the Biden administration about minor heart damage, but FOIA requests later showed active conversations up to the White House regarding myocarditis in minors. Instead of withdrawing or advising parents, a 17-page document was produced as a script to persuade parents to vaccinate their minors, supplemented by a TikTok influencer campaign encouraging young people to get injected. These communications indicated that kids would sustain deadly heart damage, and still proceeded. Senator Ron Johnson is using the work to unredact those documents and hold hearings about the cover-up. Pfizer knew all of these things.

A communication problem arose when it was intimated that vaccines would protect against getting COVID altogether, which wasn't supported by evidence. Vaccines protect against illness in the lower respiratory system, but the virus could still be carried in the upper airway and potentially spread. This led to distrust of mRNA vaccines, as people who got COVID after vaccination questioned the vaccine's effectiveness. Recent data shows that vaccines work well in preventing illness and infection, and make it unlikely that someone would pass the infection to someone else. The concern was that vaccinated people could be unwitting carriers, but recent data suggests this is very unlikely. Vaccinated people not wearing masks are not doing a disservice to their community. Unvaccinated people could be putting other unvaccinated people at risk. Institutions may require proof of vaccination, which will be a tough call.

Pfizer representatives appeared before the Senate Committee to address questions about their COVID-19 vaccine. The committee asked if Pfizer tested whether the vaccine could reduce virus transmission before its approval. Pfizer stated that their clinical trials focused on demonstrating the vaccine's safety and effectiveness in preventing illness, severe disease, and hospitalizations. The committee also questioned Pfizer's statements regarding the vaccine's ability to stop transmission. Pfizer representatives were unable to provide specific evidence for these claims and agreed to provide further information to the committee. The committee expressed concern about the discrepancy between Pfizer's statements and requested clarification on any updated statements from Pfizer officials.

Vaccination not only protects individuals but also reduces virus transmission, helping society return to normal. Current data indicates that vaccinated individuals do not carry the virus or get sick. Getting vaccinated and boosted can save lives and prevent serious illness. The goal is to stop the virus from spreading by ensuring vaccinated individuals act as dead ends for transmission. Vaccines are effective enough that when a vaccinated person is exposed, the virus cannot infect them or spread further. However, there was uncertainty about the vaccines' ability to stop transmission at the time of emergency use authorization. The data on this was limited, and it was acknowledged that the speed of development impacted the understanding of transmission prevention.

Vaccinated individuals can protect themselves and others by reducing transmission, allowing society to return to normal. Vaccines have been shown to prevent illness and decrease the spread of infection. It is crucial for people to get vaccinated and receive booster shots when eligible to save lives and prevent serious illness. The probability of reducing transmission is believed to be 100% by one speaker. The goal is to break the chain of transmission and become a dead end for the virus. Vaccinated individuals do not get infected or serve as hosts for the virus to spread. However, there were limited data on transmission when the vaccines received emergency use authorization. The speed of science was prioritized in developing the vaccines.

On COVID, there's a perception that credit isn't given where it's due. While the vaccines were developed quickly, they don't prevent infection or transmission and may have serious side effects. In hindsight, would anything be done differently? Studies on the vaccines are ongoing, and results will emerge over time. It's important to note that Pfizer marketed its vaccine as safe for pregnant women, but reports indicated that over half of the 458 pregnant women who received the vaccine experienced adverse events. The ongoing studies will help clarify these concerns.